7 completed. 7 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 1 | Completed 1 |
Follow Craniosynostoses: new trials by email Literature Review of Craniosynostoses trials Research Report on Craniosynostoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Acrocephalosyndactylia (7) · Carcinoma, Non-Small-Cell Lung (3) · Carcinoma, Transitional Cell (3) · Cholangiocarcinoma (3) · Neoplasms (2) · Breast Neoplasms (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Recurrence (1) · Small Cell Lung Carcinoma (1) · Urinary Bladder Neoplasms (1)
Bone Diseases (7) · Bone Diseases, Developmental (7) · Congenital Abnormalities (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Craniofacial Abnormalities (7) · Dysostoses (7) · Limb Deformities, Congenital (7) · Musculoskeletal Abnormalities (7) · Musculoskeletal Diseases (7) · Syndactyly (7) · Synostosis (7) · Carcinoma (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6)
pemigatinib (3) · Drug Combinations (1) · INCB 54828-101 (1) · Rogaratinib (1) · atezolizumab (1) · derazantinib (1) · erdafitinib (1)
Incyte Corporation (3) · Basilea Pharmaceutica (1) · Bayer (1) · Eisai Co., Ltd. (1) · Janssen Research & Development, LLC (1)
France (4) · Germany (4) · Italy (4) · Spain (4) · United States (4) · Japan (3) · South Korea (3) · United Kingdom (3) · Belgium (2) · China (2) · Israel (2) · Switzerland (2) · Taiwan (2) · Australia (1) · Austria (1)
Ekaterine Asatiani, MD (1) · Luisa Veronese, MD (1)
PMID 32203698, PMID 35544727, PMID 36206041, PMID 37956738, PMID 38039831, PMID 38627238, PMID 39138436
2016 (2), 2019 (2)